Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide

<table>(a) Bone marrow aspirate on diagnosis showing myeloid hyperplasia with blasts. (b) Bone marrow aspirate at diagnosis with CD34 stain.</table>

Case Reports in Oncological Medicine

fig1

Figure 1

Figure 1: Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide 

Figure 1 | Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide 